Literature DB >> 8995641

Complementation of a primer binding site-impaired murine leukemia virus-derived retroviral vector by a genetically engineered tRNA-like primer.

A H Lund1, M Duch, J Lovmand, P Jørgensen, F S Pedersen.   

Abstract

Reverse transcription of retroviral genomes is primed by a tRNA annealed to an 18-nucleotide primer binding site. Here, we present a primer complementation system to study molecular interaction of the replication machinery with the primer and primer binding site in vivo. Introduction of eight base substitutions into the primer binding site of a murine leukemia virus-based vector allowed efficient RNA encapsidation but resulted in severely reduced vector replication capacity. Replication was restored upon complementation with a synthetic gene designed to encode a complementary tRNA-like primer, but not with a noncomplementary tRNA-like molecule. The engineered primer was shown to be involved in both the initiation of first-strand synthesis and second-strand transfer. These results provide an in vivo demonstration that the retroviral replication machinery may recognize sequence complementarity rather than actual primer binding site and 3' primer sequences. Use of mutated primer binding site vectors replicating via engineered primers may add additional control features to retroviral gene transfer technology.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8995641      PMCID: PMC191172     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication.

Authors:  X Li; J Mak; E J Arts; Z Gu; L Kleiman; M A Wainberg; M A Parniak
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

2.  Analysis of the interactions of HIV1 replication primer tRNA(Lys,3) with nucleocapsid protein and reverse transcriptase.

Authors:  C Barat; O Schatz; S Le Grice; J L Darlix
Journal:  J Mol Biol       Date:  1993-05-20       Impact factor: 5.469

3.  Production of high-titer helper-free retroviruses by transient transfection.

Authors:  W S Pear; G P Nolan; M L Scott; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

4.  Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication.

Authors:  A H Lund; M Duch; J Lovmand; P Jørgensen; F S Pedersen
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

5.  Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells.

Authors:  P M Challita; D Skelton; A el-Khoueiry; X J Yu; K Weinberg; D B Kohn
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

6.  Initiation of reverse transcription of HIV-1: secondary structure of the HIV-1 RNA/tRNA(3Lys) (template/primer).

Authors:  C Isel; C Ehresmann; G Keith; B Ehresmann; R Marquet
Journal:  J Mol Biol       Date:  1995-03-24       Impact factor: 5.469

7.  A correlation between dexamethasone inducibility and basal expression levels of retroviral vector proviruses.

Authors:  M Duch; K Paludan; J Lovmand; L Pedersen; P Jørgensen; F S Pedersen
Journal:  Nucleic Acids Res       Date:  1993-10-11       Impact factor: 16.971

8.  Nuclease activities of Moloney murine leukemia virus reverse transcriptase. Mutants with altered substrate specificities.

Authors:  S W Blain; S P Goff
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

9.  Expression of human adenosine deaminase in mice after transplantation of genetically-modified bone marrow.

Authors:  M Kaleko; J V Garcia; W R Osborne; A D Miller
Journal:  Blood       Date:  1990-04-15       Impact factor: 22.113

10.  HIV-1 reverse transcriptase-associated RNase H cleaves RNA/RNA in arrested complexes: implications for the mechanism by which RNase H discriminates between RNA/RNA and RNA/DNA.

Authors:  M Götte; S Fackler; T Hermann; E Perola; L Cellai; H J Gross; S F Le Grice; H Heumann
Journal:  EMBO J       Date:  1995-02-15       Impact factor: 11.598

View more
  15 in total

1.  Selection of functional tRNA primers and primer binding site sequences from a retroviral combinatorial library: identification of new functional tRNA primers in murine leukemia virus replication.

Authors:  A H Lund; M Duch; F S Pedersen
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

2.  Identification of specific HIV-1 reverse transcriptase contacts to the viral RNA:tRNA complex by mass spectrometry and a primary amine selective reagent.

Authors:  Mamuka Kvaratskhelia; Jennifer T Miller; Scott R Budihas; Lewis K Pannell; Stuart F J Le Grice
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

3.  Essential regions of the tRNA primer required for HIV-1 infectivity.

Authors:  Q Yu; C D Morrow
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

4.  Selection of retroviral reverse transcription primer is coordinated with tRNA biogenesis.

Authors:  Nathan J Kelly; Matthew T Palmer; Casey D Morrow
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

5.  The primer binding site on the RNA genome of human and simian immunodeficiency viruses is flanked by an upstream hairpin structure.

Authors:  B Berkhout
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

6.  Cellular restriction of retrovirus particle-mediated mRNA transfer.

Authors:  Melanie Galla; Axel Schambach; Greg J Towers; Christopher Baum
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

Review 7.  Primer tRNAs for reverse transcription.

Authors:  J Mak; L Kleiman
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

8.  Transfer of primer binding site-mutated simian immunodeficiency virus vectors by genetically engineered artificial and hybrid tRNA-like primers.

Authors:  A C Hansen; T Grunwald; A H Lund; A Schmitz; M Duch; K Uberla; F S Pedersen
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

9.  Replication and pathogenicity of primer binding site mutants of SL3-3 murine leukemia viruses.

Authors:  A H Lund; J Schmidt; A Luz; A B Sørensen; M Duch; F S Pedersen
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

10.  Preferential completion of human immunodeficiency virus type 1 proviruses initiated with tRNA3Lys rather than tRNA1,2Lys.

Authors:  Z Zhang; Q Yu; S M Kang; J Buescher; C D Morrow
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.